Linagliptin Prescribing at BALSALL COMMON & MERIDEN GROUP PRACTICE
Drugs used in diabetes | Endocrine System
Items (12m)
552
Total Quantity
16.2K
NHS Cost
£18.3K
vs National Avg
+34.8%
BALSALL COMMON & MERIDEN GROUP PRACTICE prescribed 552 items of Linagliptin over the last 12 months at a cost of £18,326 to the NHS. This is 34.8% above the national average prescribing rate. Linagliptin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
54
Jun 2026
52
Jun 2026
52
Jun 2026
45
Jun 2026
47
Jun 2026
40
Jun 2026
44
Jun 2026
43
Jun 2026
46
Jun 2026
42
Jun 2026
46
Jun 2026
41
Prescribing Details
| Total Items | 552 |
|---|---|
| Total Quantity | 16,233 |
| Total NHS Cost | £18,326 |
| Presentations | 1 different forms |
| vs National Average | +34.8% |
Linagliptin Prescribing Comparison
| This practice | 552 items |
|---|---|
| National average per practice | 410 items |
| Difference | +34.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.